Need professional-grade analysis? Visit stockanalysis.com
$4.86B
29.77
N/A
N/A
SciVision Biotech Inc (1786) trades on TW in TWD. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at TWD64.50, up 1.74% from the previous close.
Over the past year, 1786 has traded between a low of TWD59.30 and a high of TWD123.00. The stock has lost 31.4% over this period. It is currently 47.6% below its 52-week high.
SciVision Biotech Inc has a market capitalization of $4.86B, with a price-to-earnings ratio of 29.77.
SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in international trade; wholesale of medical equipment and cosmetics; and provides management advisory services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan.
Side-by-side comparison against top Healthcare peers.